Although the mechanisms by which PNPLA3 polymorphism links to HCC has not completely known, it is anticipated that this genetic variant might promote hepatocarcinogenesis via metabolic disorders including obesity, diabetes, and steatohepatitis [19]. The gene discussed is PNPLA3; the disease is metabolic disease.